GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Targeted inhibition in stromal TGFβ activity in pancreatic cancer

$352,660
Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2023 · CA

Targeted inhibition in stromal TGFβ activity in pancreatic cancer

$352,660
Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2022 · CA

Development and pilot testing of a multimodal web-based program to address heavy drinking during smoking cessation

$352,656
Christopher W. Kahler · Brown University · R34 · FY2017 · AA

Galpha13 and pancreatic cancer progression

$352,649
Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2019 · CA

TOR signaling and autophagy in obesity-promoted liver tumorigenesis

$352,646
Michael Karin · University Of California, San Diego · R01 · FY2011 · CA

MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer

$352,556
Zhuoli Zhang · Northwestern University At Chicago · R01 · FY2017 · CA

Project 2: Contribution of the Stromal Microenvironment to Early Dissemination

$352,446
Mayumi Ito · New York University School Of Medicine · U54 · FY2022 · CA

Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.

$352,374
Tracy L McGaha · University Health Network · R01 · FY2024 · CA

Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells

$352,342
Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2020 · CA

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

$352,275
Asfar S Azmi · Wayne State University · R37 · FY2021 · CA

Identifying and Targeting Metabolic Dependencies in the Pancreatic Tumor Microenvironment

$352,275
Mara H. Sherman · Oregon Health & Science University · R01 · FY2018 · CA

Identifying and Targeting Metabolic Dependencies in the Pancreatic Tumor Microenvironment

$352,275
Mara H. Sherman · Oregon Health & Science University · R01 · FY2021 · CA

Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC

$352,275
Masato Yamamoto · University Of Minnesota · R01 · FY2020 · CA

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

$352,275
Asfar S Azmi · Wayne State University · R37 · FY2018 · CA

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

$352,275
Asfar S Azmi · Wayne State University · R37 · FY2022 · CA

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

$352,275
Asfar S Azmi · Wayne State University · R37 · FY2020 · CA

Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue

$352,275
Pei Wang · University Of Texas Hlth Science Center · R01 · FY2020 · CA

Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer

$352,275
Masato Yamamoto · University Of Minnesota · R01 · FY2019 · CA

Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer

$352,275
Masato Yamamoto · University Of Minnesota · R01 · FY2021 · CA

Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer

$352,275
Masato Yamamoto · University Of Minnesota · R01 · FY2020 · CA

Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies

$352,155
William Joseph Murphy · University Of California At Davis · R01 · FY2019 · CA

Mechanisms of Hereditary Pancreatitis

$352,125
Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2020 · DK

Mechanisms of Hereditary Pancreatitis

$352,125
Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2019 · DK

Mechanisms of Hereditary Pancreatitis

$352,125
Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2022 · DK

Mechanisms of Hereditary Pancreatitis

$352,125
Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2021 · DK